Literature DB >> 15455340

Absence of EGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancer.

Jong Woo Lee, Young Hwa Soung, Su Young Kim, Won Sang Park, Suk Woo Nam, Jung Young Lee, Nam Jin Yoo, Sug Hyung Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15455340     DOI： 10.1002/ijc.20591

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  9 in total

1.  Presence of EGFR mutation in pathologically non-malignant specimens from computed tomography-guided lung needle biopsies.

Authors:  Tsuyoshi Ueno; Junichi Soh; Takao Hiraki; Hiroaki Asano; Koichi Ichimura; Kentaro Shibamoto; Hideo Gobara; Susumu Kanazawa; Shinichi Toyooka; Shinichiro Miyoshi
Journal:  Oncol Lett       Date:  2011-11-03       Impact factor: 2.967

2.  Epidermal growth factor receptor domain II, IV, and kinase domain mutations in human solid tumors.

Authors:  Harri Sihto; Marjut Puputti; Laura Pulli; Olli Tynninen; Walter Koskinen; Leena-Maija Aaltonen; Minna Tanner; Tom Böhling; Tapio Visakorpi; Ralf Bützow; Aija Knuuttila; Nina N Nupponen; Heikki Joensuu
Journal:  J Mol Med (Berl)       Date:  2005-08-31       Impact factor: 4.599

3.  Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell lines.

Authors:  Laetitia Dahan; Amine Sadok; Jean-Louis Formento; Jean François Seitz; Hervé Kovacic
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

Review 4.  Mechanisms of resistance to EGFR targeted therapies.

Authors:  Gorjan Hrustanovic; Bianca J Lee; Trever G Bivona
Journal:  Cancer Biol Ther       Date:  2013-01-28       Impact factor: 4.742

5.  EGFR Signaling in Colorectal Carcinoma.

Authors:  Alyssa M Krasinskas
Journal:  Patholog Res Int       Date:  2011-02-14

6.  Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10.

Authors:  H Modjtahedi; S A Khelwatty; R S Kirk; A M Seddon; S Essapen; C A Del Vecchio; A J Wong; S Eccles
Journal:  Br J Cancer       Date:  2012-02-07       Impact factor: 7.640

7.  Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis.

Authors:  Jorge S Reis-Filho; Fernanda Milanezi; Silvia Carvalho; Pete T Simpson; Dawn Steele; Kay Savage; Maryou B K Lambros; Emilio M Pereira; Jahn M Nesland; Sunil R Lakhani; Fernando C Schmitt
Journal:  Breast Cancer Res       Date:  2005-10-25       Impact factor: 6.466

Review 8.  Molecular Diagnostics in Clinical Oncology.

Authors:  Anna P Sokolenko; Evgeny N Imyanitov
Journal:  Front Mol Biosci       Date:  2018-08-27

9.  CYTOPLASMIC-MEMBRANE EGFR PREDICTS EXPANDED RAS MUTATION STATUS IN COLORECTAL CARCINOMAS?

Authors:  Thiago David Alves Pinto; Thaís David das Neves Alves; Sebastião Alves Pinto; Enio Chaves Oliveira
Journal:  Arq Bras Cir Dig       Date:  2021-06-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.